Welcome to The Multiple Sclerosis Journey. Join us for a multimedia exploration of where MS treatment and research stands, what the future of care may hold, and the experiences of clinicians and patients as they collaborate on the frontlines of MS care.
The Multiple Sclerosis Journey will examine new insights on the importance of early diagnosis as well as accurate identification of the four MS phenotypes and how their recognition impacts treatment selection. Join us as we examine the importance of maintaining brain health in sustaining wellness and ability among patients with MS. Experience discussions of the role of patient and physician collaboration in sustaining continuity of care and in tailoring therapy to individual patient needs and preferences.

And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.

The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.

Walk with us.

Featured Articles

Projection neuron vulnerability suggests a therapeutic path

Region- and lineage-specific transcriptomic changes appear to be responsible for the characteristic pathobiology of multiple sclerosis (MS).
A study that used single-nucleus RNA sequencing to assess changes in cell lineages in MS lesions has shed light on the selective cortical neuron damage and glial activation that contribute to the progression of MS lesions.

Lydia Emily Archibald – Don’t let MS stop you from doing what you love

While in her late 30’s, Lydia awoke with numbness in her tongue. Fearing a stroke, she went to the emergency department.

Employment rates vary by country among patients with multiple sclerosis

Multiple sclerosis patients who are young, male and have mild disability are more likely to be employed, based on a recent analysis of multiple sclerosis registries across North America, Germany, and the United Kingdom.

New technology senses patient activity

Sheila DeMelle was diagnosed at age 17 with multiple sclerosis. For most of her life, her MS didn’t slow her down too much. “My disability was invisible. I knew I had it; I knew the symptoms,” but her symptoms weren’t readily apparent.

Reevaluation reveals MS misdiagnosis in 1 of 5 patients

Nearly one in five patients with a diagnosis of multiple sclerosis (MS) was found to be misdiagnosed upon further evaluation at specialized academic centers, according to a retrospective study published in Multiple Sclerosis and Related Disorders